INNOVIVA, INC. Investing Cash Flow
INNOVIVA, INC. (INVA) reported Investing Cash Flow of -$18.26 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-05
- INNOVIVA, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$55.26M, a 266.85% decline year-over-year.
- INNOVIVA, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $37.01M.
- INNOVIVA, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $23.64M.
- INNOVIVA, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $18.41M.
- INNOVIVA, INC. net cash provided by (used in) investing activities for fiscal 2025 was $40.50M.
- INNOVIVA, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$63.79M.
- INNOVIVA, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$66.76M.
- INNOVIVA, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$56.63M, a 229.53% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$55.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$18.26M 10-Q · filed 2026-08-05 | $5.38M derived: sum of 3 quarters · filed 2026-08-05 | $23.79M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $37.01M 10-Q · filed 2026-05-06 | $60.64M derived: sum of 2 quarters · filed 2026-05-06 | $79.06M derived: sum of 3 quarters · filed 2026-05-06 | $112.18M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $23.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $42.05M derived: sum of 2 quarters · filed 2026-02-25 | $75.17M derived: sum of 3 quarters · filed 2026-08-05 | $40.50M 10-K · filed 2026-02-25 |
| 2025-09-30 | $18.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $51.53M derived: sum of 2 quarters · filed 2026-08-05 | $16.86M 10-Q · filed 2025-11-05 | $1.38M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $33.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.55M 10-Q · filed 2026-08-05 | -$17.03M derived: sum of 3 quarters · filed 2026-08-05 | -$22.30M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$34.67M 10-Q · filed 2026-05-06 | -$50.15M derived: sum of 2 quarters · filed 2026-05-06 | -$55.42M derived: sum of 3 quarters · filed 2026-05-06 | -$55.42M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$15.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$20.75M derived: sum of 2 quarters · filed 2026-02-25 | -$20.75M derived: sum of 3 quarters · filed 2026-02-25 | -$63.79M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$5.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$5.27M derived: sum of 2 quarters · filed 2025-11-05 | -$48.31M 10-Q · filed 2025-11-05 | -$53.46M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$43.04M 10-Q · filed 2025-08-06 | -$48.19M derived: sum of 3 quarters · filed 2026-02-25 | -$74.08M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$43.04M 10-Q · filed 2025-05-07 | -$48.19M derived: sum of 2 quarters · filed 2026-02-25 | -$74.08M derived: sum of 3 quarters · filed 2026-02-25 | -$74.08M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$5.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$31.04M derived: sum of 2 quarters · filed 2026-02-25 | -$31.04M derived: sum of 3 quarters · filed 2026-02-25 | -$66.76M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$25.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$25.89M derived: sum of 2 quarters · filed 2024-11-06 | -$61.61M 10-Q · filed 2024-11-06 | -$70.29M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$35.72M 10-Q · filed 2024-07-31 | -$44.40M derived: sum of 3 quarters · filed 2025-02-26 | $53.32M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | -$35.72M 10-Q · filed 2024-05-08 | -$44.40M derived: sum of 2 quarters · filed 2025-02-26 | $53.32M derived: sum of 3 quarters · filed 2025-02-26 | $50.80M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | -$8.68M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $89.04M derived: sum of 2 quarters · filed 2025-02-26 | $86.52M derived: sum of 3 quarters · filed 2025-02-26 | -$56.63M 10-K · filed 2025-02-26 |
| 2022-09-30 | $97.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $95.20M derived: sum of 2 quarters · filed 2023-11-01 | -$47.96M 10-Q · filed 2023-11-01 | -$67.86M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | -$2.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$145.68M 10-Q · filed 2023-08-02 | -$165.58M derived: sum of 3 quarters · filed 2024-03-05 | -$165.58M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | -$143.16M 10-Q · filed 2023-05-09 | -$163.06M derived: sum of 2 quarters · filed 2024-03-05 | -$163.06M derived: sum of 3 quarters · filed 2024-03-05 | -$73.04M derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | -$19.91M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-05 | -$19.91M derived: sum of 2 quarters · filed 2024-03-05 | $70.12M derived: sum of 3 quarters · filed 2024-03-05 | $43.72M 10-K/A · filed 2024-03-05 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $90.02M derived: sum of 2 quarters · filed 2022-11-09 | $63.63M 10-Q · filed 2022-11-09 | -$251.85M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $90.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $63.63M 10-Q · filed 2022-07-27 | -$251.85M derived: sum of 3 quarters · filed 2023-02-28 | -$260.35M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$26.39M 10-Q · filed 2022-05-05 | -$341.88M derived: sum of 2 quarters · filed 2023-02-28 | -$350.38M derived: sum of 3 quarters · filed 2023-02-28 | -$357.38M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$315.48M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$323.98M derived: sum of 2 quarters · filed 2023-02-28 | -$330.98M derived: sum of 3 quarters · filed 2023-02-28 | -$314.94M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$8.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | -$15.50M derived: sum of 2 quarters · filed 2021-10-27 | $544.00K 10-Q · filed 2021-10-27 | $52.54M derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-06-30 | -$7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $9.04M 10-Q · filed 2021-07-29 | $61.04M derived: sum of 3 quarters · filed 2022-03-17 | $45.10M derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-03-31 | $16.04M 10-Q · filed 2021-04-28 | $68.04M derived: sum of 2 quarters · filed 2022-03-17 | $52.10M derived: sum of 3 quarters · filed 2022-03-17 | $72.21M derived: sum of 4 quarters · filed 2022-03-17 |
| 2019-12-31 | $51.99M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-17 | $36.06M derived: sum of 2 quarters · filed 2022-03-17 | $56.16M derived: sum of 3 quarters · filed 2022-03-17 | -$18.00M 10-K/A · filed 2022-03-17 |
| 2019-09-30 | -$15.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $4.17M derived: sum of 2 quarters · filed 2020-10-28 | -$70.00M 10-Q · filed 2020-10-28 | -$115.59M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $20.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$54.06M 10-Q · filed 2020-07-29 | -$99.65M derived: sum of 3 quarters · filed 2021-02-25 | -$86.13M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$74.17M 10-Q · filed 2020-04-29 | -$119.76M derived: sum of 2 quarters · filed 2021-02-25 | -$106.24M derived: sum of 3 quarters · filed 2021-02-25 | -$97.16M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$45.59M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$32.07M derived: sum of 2 quarters · filed 2021-02-25 | -$22.99M derived: sum of 3 quarters · filed 2021-02-25 | $3.52M 10-K · filed 2021-02-25 |
| 2018-09-30 | $13.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $22.60M derived: sum of 2 quarters · filed 2019-10-30 | $49.11M 10-Q · filed 2019-10-30 | $23.23M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | $9.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $35.59M 10-Q · filed 2019-07-24 | $9.71M derived: sum of 3 quarters · filed 2020-02-19 | -$12.06M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | $26.51M 10-Q · filed 2019-05-01 | $633.00K derived: sum of 2 quarters · filed 2020-02-19 | -$21.14M derived: sum of 3 quarters · filed 2020-02-19 | -$19.12M derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | -$25.88M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | -$47.65M derived: sum of 2 quarters · filed 2020-02-19 | -$45.63M derived: sum of 3 quarters · filed 2020-02-19 | -$23.24M 10-K · filed 2020-02-19 |
| 2017-09-30 | -$21.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | -$19.75M derived: sum of 2 quarters · filed 2018-10-31 | $2.64M 10-Q · filed 2018-10-31 | $25.96M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-06-30 | $2.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $24.42M 10-Q · filed 2018-07-26 | $47.74M derived: sum of 3 quarters · filed 2019-02-19 | $32.64M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-03-31 | $22.39M 10-Q · filed 2018-05-04 | $45.72M derived: sum of 2 quarters · filed 2019-02-19 | $30.62M derived: sum of 3 quarters · filed 2019-02-19 | $6.12M derived: sum of 4 quarters · filed 2019-02-19 |
| 2016-12-31 | $23.32M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $8.22M derived: sum of 2 quarters · filed 2019-02-19 | -$16.27M derived: sum of 3 quarters · filed 2019-02-19 | -$4.58M 10-K · filed 2019-02-19 |
| 2016-09-30 | -$15.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | -$39.59M derived: sum of 2 quarters · filed 2017-11-03 | -$27.90M 10-Q · filed 2017-11-03 | $71.39M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | -$24.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$12.80M 10-Q · filed 2017-08-08 | $86.48M derived: sum of 3 quarters · filed 2018-02-23 | $38.61M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | $11.69M 10-Q · filed 2016-05-05 | $110.98M derived: sum of 2 quarters · filed 2018-02-23 | $63.11M derived: sum of 3 quarters · filed 2018-02-23 | $97.15M derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | $99.29M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $51.41M derived: sum of 2 quarters · filed 2018-02-23 | $85.46M derived: sum of 3 quarters · filed 2018-02-23 | $159.17M 10-K · filed 2018-02-23 |
| 2015-09-30 | -$47.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$13.83M derived: sum of 2 quarters · filed 2016-11-03 | $59.88M 10-Q · filed 2016-11-03 | $51.47M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $34.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $107.75M 10-Q · filed 2016-08-04 | $99.34M derived: sum of 3 quarters · filed 2017-02-28 | $39.80M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $73.71M 10-Q · filed 2016-05-05 | $65.30M derived: sum of 2 quarters · filed 2017-02-28 | $5.75M derived: sum of 3 quarters · filed 2017-02-28 | -$5.48M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | -$8.41M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$67.96M derived: sum of 2 quarters · filed 2017-02-28 | -$79.19M derived: sum of 3 quarters · filed 2017-02-28 | -$65.06M 10-K · filed 2017-02-28 |
| 2014-09-30 | -$59.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$70.78M derived: sum of 2 quarters · filed 2015-11-05 | -$56.65M 10-Q · filed 2015-11-05 | -$58.08M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-06-30 | -$11.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $2.90M 10-Q · filed 2015-08-06 | $1.47M derived: sum of 3 quarters · filed 2016-02-24 | -$98.14M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-03-31 | $14.13M 10-Q · filed 2015-05-08 | $12.70M derived: sum of 2 quarters · filed 2016-02-24 | -$86.91M derived: sum of 3 quarters · filed 2016-02-24 | |
| 2013-12-31 | -$1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | -$101.03M derived: sum of 2 quarters · filed 2016-02-24 | -$219.58M 10-K · filed 2016-02-24 | |
| 2013-09-30 | -$99.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | -$218.15M 10-Q · filed 2014-11-04 | ||
| 2013-06-30 | -$118.55M 10-Q · filed 2014-08-07 | |||
| 2012-12-31 | -$58.28M 10-K · filed 2015-02-27 | |||
| 2011-06-30 | -$50.47M 10-Q · filed 2011-08-03 | |||
| 2010-06-30 | -$33.47M 10-Q · filed 2011-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |